<?xml version="1.0" encoding="UTF-8"?>
<ref id="B142-molecules-24-01913" class="ref">
 <label class="label">142.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Rescigno</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Casa√±ola-Martin</surname>
    <given-names class="given-names">G.M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Sanjust</surname>
    <given-names class="given-names">E.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Zucca</surname>
    <given-names class="given-names">P.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Marrero-Ponce</surname>
    <given-names class="given-names">Y.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Vanilloid derivatives as tyrosinase inhibitors driven by virtual screening-based QSAR models</article-title>
  <source class="source">Drug Test. Anal.</source>
  <year class="year">2011</year>
  <volume class="volume">3</volume>
  <fpage class="fpage">176</fpage>
  <lpage class="lpage">181</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1002/dta.187</pub-id>
  <pub-id pub-id-type="pmid" class="pub-id">21125547</pub-id>
 </element-citation>
</ref>
